Meld Valuation / Venture NAV Tracker
FundsCompaniesMethodology
meldvaluation.com ↗

Venture NAV Tracker / Private company

Replimune Group, Inc.

Drug Discovery & Development
Headquarters—
Founded—
Last known round—
Reported valuation—

Cross-fund comparison

Current disclosed marks

One latest disclosed debt mark per fund.

FundSecurity type / basisPrincipalFair valueFV / principalRateMaturityMark age vs roundNon-accrual
HTGCHercules Capital, Inc.senior secured loanFair Value — Senior Secured$57MMar 31, 2026 · source ↗$58MMar 31, 2026 · source ↗101.6%Mar 31, 2026 · source ↗Prime + 1.75 %, Floor rate 8.50 %, Cap rate 9.00 %, PIK Interest 1.50 %, 4.95 % Exit FeeMar 31, 2026 · source ↗Oct 1, 2027Mar 31, 2026 · source ↗—Mar 31, 2026 · source ↗NoMar 31, 2026 · source ↗

Historical marks

Reported fair value by fund

Each bar is a disclosed position-quarter.

$58MHTGCMar 31, 2026 · source ↗
Figures are compiled from public filings.Read methodologyMELD Valuation